EGFR and chronic myelogenous leukemia, BCR-ABL1 positive: Pathway analysis of hsa-miR-4732-5p extracted “ErbB signaling pathway,” “Melanoma,” and “Chronic myeloid leukemia” (P = 0.015, 0.042 and 0.047, respectively, Table 4A).